FDA Approved: DANZITEN — Original Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the Original Application for DANZITEN (nilotinib) from Azurity Pharmaceuticals, establishing a branded nilotinib product for Philadelphia chromosom…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia

Drugs mentioned

• DANZITEN (NILOTINIB)

Snippet

ORIG AP for DANZITEN (NILOTINIB)